Two Sigma Advisers’s ChemoCentryx, Inc. CCXI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-47,341
| Closed | -$2.45M | – | 2786 |
|
|
2022
Q3 | $2.45M | Sell |
47,341
-109,300
| -70% | -$5.65M | 0.01% | 1069 |
|
|
2022
Q2 | $3.88M | Sell |
156,641
-63,300
| -29% | -$1.57M | 0.01% | 878 |
|
|
2022
Q1 | $5.51M | Buy |
219,941
+135,800
| +161% | +$3.4M | 0.01% | 763 |
|
|
2021
Q4 | $3.06M | Buy |
+84,141
| New | +$3.06M | 0.01% | 989 |
|
|
2021
Q3 | – | Sell |
-11,441
| Closed | -$153K | – | 2762 |
|
|
2021
Q2 | $153K | Sell |
11,441
-20,800
| -65% | -$278K | ﹤0.01% | 2304 |
|
|
2021
Q1 | $1.65M | Sell |
32,241
-170,000
| -84% | -$8.71M | ﹤0.01% | 1364 |
|
|
2020
Q4 | $12.5M | Sell |
202,241
-77,700
| -28% | -$4.81M | 0.03% | 494 |
|
|
2020
Q3 | $15.3M | Buy |
279,941
+41,900
| +18% | +$2.3M | 0.04% | 391 |
|
|
2020
Q2 | $13.7M | Buy |
238,041
+97,500
| +69% | +$5.61M | 0.04% | 437 |
|
|
2020
Q1 | $5.65M | Sell |
140,541
-56,100
| -29% | -$2.25M | 0.02% | 669 |
|
|
2019
Q4 | $7.78M | Sell |
196,641
-91,000
| -32% | -$3.6M | 0.02% | 674 |
|
|
2019
Q3 | $1.95M | Sell |
287,641
-24,300
| -8% | -$165K | ﹤0.01% | 1125 |
|
|
2019
Q2 | $2.9M | Buy |
311,941
+73,324
| +31% | +$682K | 0.01% | 1042 |
|
|
2019
Q1 | $3.31M | Buy |
238,617
+23,376
| +11% | +$325K | 0.01% | 993 |
|
|
2018
Q4 | $2.35M | Sell |
215,241
-12,900
| -6% | -$141K | 0.01% | 1104 |
|
|
2018
Q3 | $2.88M | Sell |
228,141
-26,500
| -10% | -$335K | 0.01% | 1052 |
|
|
2018
Q2 | $3.35M | Buy |
254,641
+227,441
| +836% | +$3M | 0.01% | 1048 |
|
|
2018
Q1 | $370K | Buy |
27,200
+14,500
| +114% | +$197K | ﹤0.01% | 1939 |
|
|
2017
Q4 | $76K | Hold |
12,700
| – | – | ﹤0.01% | 2172 |
|
|
2017
Q3 | $94K | Buy |
+12,700
| New | +$94K | ﹤0.01% | 2119 |
|
|
2016
Q2 | – | Sell |
-15,441
| Closed | -$38K | – | 2238 |
|
|
2016
Q1 | $38K | Buy |
+15,441
| New | +$38K | ﹤0.01% | 1999 |
|